BSE filing, NSE: TORNTPHARM. Summary written from the filing by ALFA Finder's alert engine.
Torrent Pharmaceuticals Ltd: key numbers
- Share price
- ₹4,650.00
- Market cap
- ₹1,76,871 Cr
- Revenue (annual)
- ₹13,980 Cr
- Net profit (annual)
- ₹2,163 Cr
- P/E (TTM)
- 83.3×Sector 47.2×
- Promoter holding
- 60.78%-7.53% QoQ
- FII holding
- 17.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Torrent Pharmaceuticals Ltd
All →Torrent Pharmaceuticals Earnings Call Transcript: Key Takeaways
Revenue grew 51% following the JB Chemicals merger, but underlying business shows integration headwinds.
- Call
- Guides 10% growth
Torrent Pharmaceuticals Debt & Borrowing
Torrent Pharmaceuticals filed its security cover certificate as on 30-Sep-26 for listed NCDs, showing 141% market-value cover. Secured debt covered by the certificate stands at Rs 11,578.42 Crore.
Torrent Pharmaceuticals Q2 FY27 Results: Net Profit ₹534 Cr, Down 9.6% YoY
Torrent Pharmaceuticals Ltd reported revenue from operations of ₹4,979 Cr (+50.8% YoY) and net profit of ₹534 Cr (-9.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹534 Cr · -9.6% YoY
Torrent Pharmaceuticals Management Change
Torrent Pharmaceuticals' Executive Director, Amal Kelshikar, has resigned from his position effective October 16, 2026.
Torrent Pharmaceuticals Credit Rating
India Ratings affirmed Torrent Pharmaceuticals' existing credit ratings and revised the outlook to positive. The company's commercial paper rating was also affirmed and assigned.
Torrent Pharmaceuticals Board Meeting Date
Torrent Pharmaceuticals will hold a board meeting on 23-Oct-26 to consider standalone audited and consolidated unaudited financial results for the quarter and half-year ended 30-Sep-26.
Other merger & restructuring announcements
All →Godawari Power & Ispat Merger & Restructuring Worth ₹10.95 Cr
GPIL sold 3,67,200 Jammu Pigments shares for Rs 10.95 Crore, cutting its stake from 38.27% to 36.38%. This third tranche is part of a wider associate divestment.
- Value
- ₹10.95 Cr
Hinduja Global Solutions Merger & Restructuring
Hinduja Global Solutions updated on its subsidiary IMCL's plan to sell its entire stake in Bhima Riddhi and Vinsat to external buyers. Completion is taking longer, and both will cease to be step-down subsidiaries on completion.
Ganesh Benzoplast Merger & Restructuring Worth ₹1,066 Cr
Ganesh Benzoplast seeks shareholder approval via postal ballot for a Rs 1,066 Crore slump sale of its liquid storage terminal business to Cisternina Logistics, and a rail logistics business transfer. E-voting runs 6 November to 5 December 2026.
- Value
- ₹1,066 Cr
Ceigall India Merger & Restructuring Worth ₹86.32 Cr
Ceigall India Ltd will infuse Rs. 86.32 Crore into its step-down subsidiary, Ceigall Ambala Chandigarh Zirakpur Limited. The investment supports a 6-lane spur connectivity highway project in Punjab.
- Value
- ₹86.32 Cr
- highway length
- 10.3 Km
Computer Age Management Services Merger & Restructuring
CAMS disclosed the voluntary liquidation and dissolution of its non-material step-down subsidiary Think Analytics under IBC Section 59. The closure has no impact on company operations.
India Glycols Merger & Restructuring
India Glycols disclosed that IGL Spirits received BSE and NSE listing approval for 6.70 crore demerger shares. Trading in these equity shares begins on 4 November 2026.